Patterson Companies (PDCO) : 2 brokerage houses believe that Patterson Companies (PDCO) is a Strong Buy at current levels. 4 analysts believe that the current prices are in a balance with the stocks fundamentals, hence they propose Hold on Patterson Companies (PDCO). Zacks Investment Research suggests a Sell with a rank of 4. 1 analysts perceive the stock to be overvalued at the existing levels, hence their call is to Sell the stock.The median of all the 7 Wall Street Analysts endorse the stock as a Hold with a rating of 2.57.
Patterson Companies (PDCO) : 4 investment research analysts covering Patterson Companies (PDCO) have an average price target of $52 for the near short term. The highest target price given by the Brokerage Firm to the stock is $65 and the lowest target is $44 for the short term. Analysts expect the variance to be within $9.06 of the average price.
Also, Brokerage firm Baird maintains its rating on Patterson Companies (NASDAQ:PDCO). As per the latest information, the brokerage house lowers the price target to $49 per share from a prior target of $51. The shares have been rated Neutral. The rating by the firm was issued on August 26, 2016.
Patterson Companies (NASDAQ:PDCO): After opening at $45.37, the stock dipped to an intraday low of $45.31 on Thursday. However, the bulls stepped in to buy at lower levels and pushed the stock higher. The stock touched an intraday high of $46.13 and the buying power remained strong till the end. The stock closed at $46.03 for the day, a gain of 1.54% for the day session. The total traded volume was 663,191. The stocks close on the previous trading day was $45.33.
Patterson Companies, Inc. is a distributor serving the dental, veterinary and rehabilitation supply markets. The Company operates through three segments: dental supply, veterinary supply and rehabilitation supply. The Companys dental supply segment provides consumable products (including x-ray film, restorative materials, hand instruments and sterilization products); basic and advanced technology dental equipment; practice management and clinical software; patient education systems, and office forms and stationery. The Companys veterinary supply segment distributes veterinary supplies to companion-pet (dogs, cats and other common household pets), equine and large animal veterinarians and veterinary clinics, public and private institutions and shelters across the United States and in the United Kingdom. The rehabilitation supply segment distributes rehabilitation medical supplies and equipment.